Patent · US Active

Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts

US10106788B2 · kind B2 · utility

2Cited by
18References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 17, 2011
Grant dateOct 23, 2018
Priority date
Expiry dateJul 17, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/52
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure provides methods of integrating therapeutic protein and antibody generation and/or selection, evolution and expression in a eukaryotic host for manufacturing in a single system. Therapeutic proteins, including antibodies, are generated, optimized and manufactured in the same eukaryotic host system. The disclosed system of Comprehensive Integrated Antibody Optimization (CIAO!™) allows for simultaneous evolution of protein performance and expression optimization.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.